Inventor · disambiguated record
Edward B. Reilly
Also filed as: REILLY EDWARD · REILLY EDWARD B
10 granted patents·30 pending applications·118 citations·filing 2002–2025
90Inventor score
Top patents by PatentIndex Score
40 records- 0195US9493568B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2015·Granted Nov 15, 2016·19 cites·22 claims
- 0294US9029508B2Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2009·Granted May 12, 2015·57 cites·22 claims
- 0392US10383948B2Anti-cMet antibody drug conjugates and methods for their useABBVIE INC·Filed 2018·Granted Aug 20, 2019·10 cites·12 claims
- 0491US10603389B2Anti-cMet antibody drug conjugates and methods for their useABBVIE INC·Filed 2019·Granted Mar 31, 2020·3 cites·4 claims
- 0589US9725515B2Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2013·Granted Aug 8, 2017·10 cites·50 claims
- 0688US2025163159A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 0785US9827330B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2016·Granted Nov 28, 2017·3 cites·21 claims
- 0885US7396913B2Erythropoietin receptor binding antibodiesABBOTT LAB·Filed 2003·Granted Jul 8, 2008·12 cites·11 claims
- 0983US10098968B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Granted Oct 16, 2018·2 cites·13 claims
- 1081US2023321271A1ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1179US10112999B2Anti-PRLR antibody-drug conjugates (ADC) and uses thereofABBVIE INC·Filed 2018·Granted Oct 30, 2018·1 cites·11 claims
- 1278US2022288221A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2021·Application pending·0 cites
- 1372US10184003B2Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2016·Granted Jan 22, 2019·1 cites·30 claims
- 1471US2020405878A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2020·Application pending·0 cites
- 1570US2022306740A1Bispecific binding moleculesABBVIE INC·Filed 2021·Application pending·0 cites
- 1668US2025304691A1Bispecific binding moleculesABB VIE INC·Filed 2025·Application pending·0 cites
- 1767US2021253700A1Bispecific binding moleculesABBVIE INC·Filed 2021·Application pending·0 cites
- 1866US2020215200A1ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE INC·Filed 2020·Application pending·0 cites
- 1966US2019134216A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2018·Application pending·0 cites
- 2065US2019010237A1Anti-prlr antibody-drug conjugates (adc) and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 2165US2021312797A9Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 2263US2021061916A1Anti-prlr antibody-drug conjugates (adc) and uses thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 2360US2009252746A1Erythropoietin receptor binding antibodiesABBOTT LAB·Filed 2008·Application pending·0 cites
- 2458US2008095776A1Erythropoietin receptor binding antibodiesABBOTT LAB·Filed 2007·Application pending·0 cites
- 2558US2019153110A1Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 2658US2017348429A1ANTI-cMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2757US2015017168A1Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2014·Application pending·0 cites
- 2852US2005227289A1Antibodies to erythropoietin receptor and uses thereofREILLY EDWARD B·Filed 2004·Application pending·0 cites
- 2951US2010260668A1Dual Variable Domain Immunoglobulins and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 3051US2011313230A1Specific binding proteins and uses thereofJOHNS TERRANCE GRANT·Filed 2011·Application pending·0 cites
- 3151US2015104452A1Dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 3249US2016319026A1Dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2016·Application pending·0 cites
- 3349US2020297863A1Anti-egfr antibody drug conjugates (adc) and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 3449US2020188525A1Anti-egfr antibody drug conjugates (adc) and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 3548US2011263827A1Dual Variable Domain Immunnoglobulins and Uses ThereofABBOTT LAB·Filed 2010·Application pending·0 cites
- 3646US2004071694A1Erythropoietin receptor binding antibodiesFiled 2002·Application pending·0 cites
- 3744US2008038265A1Antibodies to Erythropoietin Receptor and Uses ThereofREILLY EDWARD B·Filed 2006·Application pending·0 cites
- 3842US2011293511A1Specific binding proteins and uses thereofJOHNS TERRANCE GRANT·Filed 2011·Application pending·0 cites
- 3940US2006018902A1Antibodies to erythropoietin receptor and uses thereofREILLY EDWARD B·Filed 2005·Application pending·0 cites
- 4037US2011223176A1Basigin binding proteinsABBOTT LAB·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →